Excellent analysis of Novo Nordisk !!!! (I have it in my PTF). In my opinion, A key factor for income-focused investors will be whether its dividend growth rate (DGR) can keep pace with earnings, or if capital will be prioritized for R&D and expansion.
Excellent analysis of Novo Nordisk !!!! (I have it in my PTF). In my opinion, A key factor for income-focused investors will be whether its dividend growth rate (DGR) can keep pace with earnings, or if capital will be prioritized for R&D and expansion.
Novo remains interesting. I started my position in April and it's still at a decent price imo
Novo truly is, yes. Still highly undervalued, even considering the ‘risks’.